Notes from the Field: Postflooding Leptospirosis — Louisiana, 2016
Weekly / October 27, 2017 / 66(42);1158–1159
Alean A. Frawley, DO1,2; Ilana J. Schafer, DVM3; Renee Galloway, MPH3; Aileen Artus, MPH3; Raoult C. Ratard, MD1 (View author affiliations)View suggested citation
In August 2016, extensive flooding occurred in south-central Louisiana. Approximately 1 month after the flood, the Louisiana Office of Public Health received notification through electronic laboratory reporting of two patients with serologic evidence of leptospirosis (immunoglobulin M antibodies to Leptospira species). Both patients were hospitalized with severe illness at the time of laboratory testing and recovered after appropriate treatment. Hospital record review revealed that both patients were exposed to floodwater before illness onset. Because these two (sentinel) patients with leptospirosis represented a marked increase over the three cases reported in their respective parishes of residence during the previous 28 years (1), an investigation was undertaken to identify other cases of leptospirosis related to the 2016 flood.
Leptospirosis is a bacterial disease caused by infection with pathogenic Leptospira species (2). Humans can be infected through direct contact with urine from an infected animal or by contact with urine-contaminated soil or water, often during flooding (3). Approximately 90% of patients with leptospirosis experience a nonspecific, self-limited illness with symptoms of fever, chills, nausea, or headache (2). Pain in the calf and low back muscles and conjunctival suffusion without purulent discharge are distinctive features (2). Approximately 10% of patients develop severe illness, which is characterized by any combination of jaundice, renal failure, aseptic meningitis, cardiac arrhythmia, gastrointestinal symptoms, pulmonary hemorrhage, or circulatory collapse and is associated with a 5%–15% case fatality rate (2).
Suspected leptospirosis cases were defined as the occurrence of fever with at least two nonspecific symptoms (myalgia, headache, jaundice, conjunctival suffusion, or maculopapular or petechial rash), or at least one diagnosis indicating severe illness (aseptic meningitis, renal insufficiency, pulmonary complications, electrocardiogram abnormalities, gastrointestinal symptoms, hemorrhage, or jaundice with acute renal failure) during August 13–September 21, 2016 in a patient exposed to floodwater (4). The Louisiana Early Events Detection System (LEEDS), a statewide electronic syndromic surveillance system, was queried to identify patients treated in hospitals serving the flood region during August 13–September 21 who had signs, symptoms, or diagnoses compatible with leptospirosis. The dates were selected to include the flooding period (August 11–August 20) and a leptospirosis incubation period beginning 2 days after flooding started and continuing through 30 days after water recession (2). Hospital records of patients meeting the symptoms or diagnosis components of the case definition were reviewed; patients without fever or with laboratory evidence supporting an alternative diagnosis were eliminated. The remaining patients were interviewed to ascertain floodwater exposure; those with floodwater exposure provided whole blood and urine specimens for leptospirosis polymerase chain reaction (PCR) testing and a serum specimen for microscopic agglutination test (MAT) testing. MAT was also performed on serum from both sentinel patients. An acute urine specimen from one sentinel patient was tested by PCR. All laboratory testing was performed by CDC.
LEEDS queries yielded 69 patients warranting medical record review. After eliminating patients who did not meet the case definition based on medical record review, 13 of 18 patients who met the case definition were contacted for interview; among these, four reported floodwater exposure and submitted blood and urine specimens. MAT and PCR were negative for Leptospira spp. infection among all LEEDS-identified patients. Leptospirosis was confirmed by MAT in both sentinel patients; urine PCR identified Leptospira kirschneri DNA in one sentinel patient.
Leptospira species are prevalent among Louisiana wildlife. According to the Louisiana Department of Wildlife and Fisheries (LDWF), anti-Leptospira spp. seroprevalence in the Louisiana feral swine population was 71% in 2015 (Rusty Berry, DVM, LDWF, personal communication, November 9, 2016), which is markedly higher than the 26% estimated by the United States Department of Agriculture in 2012 (5). LDWF surveillance also identified a substantial increase in leptospirosis in the deer population, from an average seroprevalence of 7% during 2007–2012 to 42% during the 2015–2016 hunting season. (Rusty Berry, DVM, LDWF, personal communication, November 9, 2016 and July 6, 2017).
No additional confirmed cases of postflooding leptospirosis were identified. Nonetheless, cases might have been missed because of flood-related access to care difficulties and patients not seeking medical care for less than severe illness. However, given the endemicity of Leptospira spp. among Louisiana wildlife, including documented L. kirschneri in feral swine isolates (6), and the two recent flood-related cases of leptospirosis, a high index of suspicion for leptospirosis among patients with compatible symptoms and exposure to untreated water is warranted, especially during flooding. Educating the public about leptospirosis prevention and clinicians about its clinical presentation might decrease the prevalence of severe disease by enabling early identification and treatment.
Rusty Berry, Louisiana Department of Wildlife and Fisheries; Angie Orellana, Gillian Richardson, Lauren Elmendorf, Infectious Disease Epidemiology Section, Louisiana Office of Public Health.
Conflict of Interest
No conflicts of interest were reported.
Corresponding author: Alean A. Frawley, email@example.com, 504-568-8327.
1Infectious Disease Epidemiology Section, Louisiana Department of Health; 2Epidemic Intelligence Service, CDC; 3Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC.
- Louisiana Office of Public Health. Leptospirosis annual report 2016. Leptospirosis. Baton Rouge, LA: Louisiana Office of Public Health; 2017. http://new.dhh.louisiana.gov/assets/oph/Center-PHCH/Center-CH/infectious-epi/Annuals/Leptospirosis_LaIDAnnual.pdfCdc-pdfExternal
- American Academy of Pediatrics. Leptospirosis. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red book: 2015 report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015:510–13. https://redbook.solutions.aap.org/book.aspx?bookid=1484External
- CDC. Leptospirosis infection. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. https://www.cdc.gov/leptospirosis/infection/index.html
- CDC. Leptospirosis (Leptospira interrogans) 2013 case definition. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. https://wwwn.cdc.gov/nndss/conditions/leptospirosis/case-definition/2013/
- United States Department of Agriculture, Animal and Plant Health Inspection Service, National Wildlife Research Center. National Wildlife Disease Program fiscal year 2012 annual report. Washington DC: United States Department of Agriculture, Animal and Plant Inspection Service, National Wildlife Research Center; 2012. https://www.aphis.usda.gov/wildlife_damage/nwdp/pdf/NWDP%202012%20Annual%20Report%20Final.pdfCdc-pdfExternal
- LaCour JM. Feral hogs in Louisiana: an overview. Presented at the Louisiana Department of Wildlife and Fisheries. Baton Rouge, LA; April 3, 2014. http://www.wlf.louisiana.gov/sites/default/files/pdf/document/37570-feral-hogs-louisiana-overview-commission-meeting-webpost-4-3-14-kr-bb/feral_hogs_in_louisiana_an_overview_commission_meeting_for_webpost_4_3_14_kr_bb.pdfCdc-pdfExternal
Suggested citation for this article: Frawley AA, Schafer IJ, Galloway R, Artus A, Ratard RC. Notes from the Field: Postflooding Leptospirosis — Louisiana, 2016. MMWR Morb Mortal Wkly Rep 2017;66:1158–1159. DOI: http://dx.doi.org/10.15585/mmwr.mm6642a9External.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to firstname.lastname@example.org.